Immunological Responses Following Administration of a Genotype 1a/1b/2/3a Quadrivalent HCV VLP Vaccine

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-24762-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pre-Clinical Evaluation of a Quadrivalent HCV VLP Vaccine in Pigs Following Microneedle Delivery

Scientific Reports
Multidisciplinary
2019English

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

BMC Gastroenterology
MedicineGastroenterology
2012English

HCV Genotype 1 Subtypes (1a and 1b): Similarities and Differences in Clinical Features and Therapeutic Outcome

Hepatology International
Hepatology
2014English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Hepatology
MedicineHepatology
2018English

Anti-Thyroid Antibodies in Patients With HCV Genotype 3a: A Pilot Study

British Microbiology Research Journal
2016English

Elicitation of Protective Immune Responses Using a Bivalent H5N1 VLP Vaccine

Virology Journal
VirologyInfectious Diseases
2008English

Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific Region

PLoS ONE
Multidisciplinary
2013English

Cardiovascular Responses Following Immunological Sympathectomy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1964English

Economic Evaluation of Abbvie’s Regimen (Viekirax/Exviera) for Patients With Genotype 1a HCV in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy